Melville, Australia

Maria Maud L Eijkenboom

This inventor holds 1 USPTO granted patent. Top assignee: Cambridge Scientific Pty Ltd. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maria Maud L Eijkenboom. Retrieved from https://idiyas.com/inventor/maria-maud-l-eijkenboom

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Maria Maud L Eijkenboom: Innovator in COX-2 Inhibition

Introduction

Maria Maud L Eijkenboom is a notable inventor based in Melville, Australia. She has made significant contributions to the field of pharmaceuticals, particularly in the development of COX-2 inhibitors. Her work focuses on creating agents that exhibit COX-2 inhibition activity, which is crucial for various therapeutic applications.

Latest Patents

Maria holds a patent for a COX-2 inhibitor. The present invention relates to an agent having COX-2 inhibition activity. In particular, the invention involves a COX-2 inhibitor that is separated from a mixture of denatured plasma and at least one metal, metal ion, or metal salt thereof. This innovative approach has the potential to enhance the efficacy of treatments targeting inflammation and pain.

Career Highlights

Maria is associated with Cambridge Scientific Pty Ltd, where she applies her expertise in pharmaceutical research and development. Her role at the company allows her to contribute to advancements in medical science, particularly in the area of drug formulation and efficacy.

Conclusion

Maria Maud L Eijkenboom is a pioneering inventor whose work in COX-2 inhibition represents a significant advancement in pharmaceutical innovation. Her contributions continue to impact the field positively, showcasing the importance of research and development in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…